Recruitment Status : Not yet recruiting, First Posted : March 17, 2021, Last Update Posted : March 17, 2021
Description of the trial: to assess the effect of Calcitriol 0.25mcg/24h for a year in the neurological function of FA patients.
Main objective of the trial: to evaluate the effects of Calcitriol in the neurological symptoms of patients with FA.
The second objectives of the trial are:
To evaluate the safety and the risk of hypercalcemia with the treatment with low dosis of Calcitriol (0.25mcg of Calcitriol every 24h) in patients with FA.
To measure de change in the Frataxin's levels during the treatment with Calcitriol.
To evaluate the effects of Calcitriol in the daily life activities and the life quality of the patients with FA.
Sample size: The number of participants needed to compleat the trial is 20.
Ages Eligible for Study: 16 Years to 65 Years (Child, Adult, Older Adult)
Duration: The duration of the trial is one year
Locations: Spain, Hospital Santa Caterina/Parc Martà i Julià , Salt, Spain, 17190
